- Home
- KALV vs NPK Comparison
KALV vs NPK Comparison
Compare KALV & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- NPK
- Stock Information
- Founded
- KALV N/A
- NPK 1905
- Country
- KALV United States
- NPK United States
- Employees
- KALV N/A
- NPK N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- NPK Ordnance And Accessories
- Sector
- KALV Health Care
- NPK Industrials
- Exchange
- KALV Nasdaq
- NPK Nasdaq
- Market Cap
- KALV 563.1M
- NPK 623.5M
- IPO Year
- KALV N/A
- NPK N/A
- Fundamental
- Price
- KALV $12.00
- NPK $83.24
- Analyst Decision
- KALV Strong Buy
- NPK
- Analyst Count
- KALV 8
- NPK 0
- Target Price
- KALV $24.83
- NPK N/A
- AVG Volume (30 Days)
- KALV 729.1K
- NPK 42.9K
- Earning Date
- KALV 03-12-2025
- NPK 05-09-2025
- Dividend Yield
- KALV N/A
- NPK 1.20%
- EPS Growth
- KALV N/A
- NPK 19.60
- EPS
- KALV N/A
- NPK 5.82
- Revenue
- KALV N/A
- NPK $388,228,000.00
- Revenue This Year
- KALV N/A
- NPK N/A
- Revenue Next Year
- KALV N/A
- NPK N/A
- P/E Ratio
- KALV N/A
- NPK $14.31
- Revenue Growth
- KALV N/A
- NPK 13.88
- 52 Week Low
- KALV $7.30
- NPK $69.58
- 52 Week High
- KALV $15.50
- NPK $103.93
- Technical
- Relative Strength Index (RSI)
- KALV 55.34
- NPK 37.03
- Support Level
- KALV $11.42
- NPK $81.57
- Resistance Level
- KALV $12.35
- NPK $85.75
- Average True Range (ATR)
- KALV 0.96
- NPK 3.10
- MACD
- KALV 0.04
- NPK 0.15
- Stochastic Oscillator
- KALV 88.74
- NPK 43.19
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.
About NPK National Presto Industries Inc.
National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments viz Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.